Amica Mutual Insurance Co. Sells 6,823 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Amica Mutual Insurance Co. decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 23.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,728 shares of the company’s stock after selling 6,823 shares during the quarter. Amica Mutual Insurance Co.’s holdings in HealthEquity were worth $1,441,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. McGlone Suttner Wealth Management Inc. bought a new stake in HealthEquity during the 4th quarter valued at approximately $29,000. DekaBank Deutsche Girozentrale acquired a new position in HealthEquity in the 3rd quarter valued at approximately $41,000. Fifth Third Bancorp raised its holdings in HealthEquity by 36.5% in the 3rd quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after acquiring an additional 161 shares in the last quarter. Operose Advisors LLC acquired a new position in HealthEquity in the 3rd quarter valued at approximately $44,000. Finally, Covestor Ltd raised its holdings in HealthEquity by 92.9% in the 3rd quarter. Covestor Ltd now owns 1,119 shares of the company’s stock valued at $82,000 after acquiring an additional 539 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 0.0 %

HealthEquity stock traded up $0.04 during mid-day trading on Monday, hitting $80.30. 323,261 shares of the company’s stock were exchanged, compared to its average volume of 594,900. HealthEquity, Inc. has a fifty-two week low of $48.86 and a fifty-two week high of $84.49. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $6.89 billion, a P/E ratio of 125.00, a PEG ratio of 1.31 and a beta of 0.53. The company’s 50 day simple moving average is $81.01 and its 200-day simple moving average is $74.49.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. The firm had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. On average, equities analysts anticipate that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

Analyst Ratings Changes

HQY has been the subject of a number of recent research reports. Barclays increased their target price on HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a report on Friday, February 23rd. JPMorgan Chase & Co. increased their target price on shares of HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 2nd. BTIG Research boosted their price target on shares of HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th. KeyCorp lifted their target price on shares of HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, March 22nd. Finally, Royal Bank of Canada raised their price target on HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, March 20th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $96.17.

Insider Buying and Selling at HealthEquity

In related news, Director Evelyn S. Dilsaver sold 32,500 shares of the stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the transaction, the director now owns 32,123 shares in the company, valued at $2,547,032.67. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Evelyn S. Dilsaver sold 32,500 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the sale, the director now owns 32,123 shares in the company, valued at approximately $2,547,032.67. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Jon Kessler sold 33,765 shares of the stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares of the company’s stock, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. In the last quarter, insiders have sold 71,322 shares of company stock worth $5,682,895. Corporate insiders own 2.70% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.